×

Compositions for regenerating defective or absent myocardium

  • US 10,624,993 B2
  • Filed: 07/18/2017
  • Issued: 04/21/2020
  • Est. Priority Date: 07/15/2005
  • Status: Active Grant
First Claim
Patent Images

1. An injectable graft composition for myocardial tissue regeneration, comprising extracellular matrix (ECM) from mammalian heart tissue, said ECM subjected to a decellularization process, wherein endogenous cells and endogenous glycosaminoglycan (GAG) proteins are extracted from said ECM,said ECM comprising exogenously added GAG proteins, said exogenously added GAG proteins being added to said ECM after said decellularization process is complete,said exogenously added GAG proteins replacing said endogenous GAG proteins extracted from said ECM during said decellularization process, wherein bioactivity of said ECM in vivo is maintained.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×